DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)

Jan Folkvard Evensen, Hanne Sand Hansen, Marie Overgaard, Jørgen Johansen, Lisbeth Juhler Andersen, Jens Overgaard*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftLetterForskningpeer review

OriginalsprogEngelsk
TidsskriftActa Oncologica
ISSN0284-186X
DOI
StatusE-pub ahead of print - 8. jul. 2019

Citer dette

@article{598ae2dd20154e2ea95dda514fe56368,
title = "DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)",
author = "Evensen, {Jan Folkvard} and {Sand Hansen}, Hanne and Marie Overgaard and J{\o}rgen Johansen and Andersen, {Lisbeth Juhler} and Jens Overgaard",
year = "2019",
month = "7",
day = "8",
doi = "10.1080/0284186X.2019.1629012",
language = "English",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Taylor & Francis",

}

DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC). / Evensen, Jan Folkvard; Sand Hansen, Hanne; Overgaard, Marie; Johansen, Jørgen; Andersen, Lisbeth Juhler; Overgaard, Jens.

I: Acta Oncologica, 08.07.2019.

Publikation: Bidrag til tidsskriftLetterForskningpeer review

TY - JOUR

T1 - DAHANCA 9–a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)

AU - Evensen, Jan Folkvard

AU - Sand Hansen, Hanne

AU - Overgaard, Marie

AU - Johansen, Jørgen

AU - Andersen, Lisbeth Juhler

AU - Overgaard, Jens

PY - 2019/7/8

Y1 - 2019/7/8

U2 - 10.1080/0284186X.2019.1629012

DO - 10.1080/0284186X.2019.1629012

M3 - Letter

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

ER -